Publication | Open Access
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
54
Citations
38
References
2021
Year
Metabolic SyndromeHepatologyBiochemistryNonalcoholic Fatty Liver DiseaseMedicineLiver PhysiologyPathologyHepatotoxicityLiver DiseaseFatty Liver DiseaseMetabolomicsMetabolismPharmacologyLipid SynthesisOxidative StressHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1